Researchers from the Korea Institute of Machinery and Materials (KIMM) and the Korea Research Institute of Bioscience and Biotechnology (KRIBB) have achieved a groundbreaking advancement in cancer treatment through their innovative 3D bioprinting technology. This cutting-edge approach utilizes natural killer cells (NK cells) for highly effective immunotherapy against cancer.
In traditional immunotherapy methods, the intravenous injection of NK cells has faced challenges in effectively treating solid tumors due to their limited viability and targeting capabilities. However, the newly developed 3D bioprinting technique by Korean research institutes addresses these issues head-on. By encapsulating NK cells within 3D-printed hydrogels, the technology prevents cell loss and enables a large number of NK cells to specifically target tumor cells.
Continue reading… “Advancing Cancer Treatment: 3D Bioprinting Boosts NK Cell Immunotherapy”
